C-RAD Investor Relations Material
Latest events
Q4 2023
C-RAD
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from C-RAD
Access all reports
Segment Data
Access more data
Revenue by
Geography
Asia
RoE Rest of Europe)
U.S.
DACH
Other
Expenses by
Financials
C-Rad AB, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer. The company offers its products under the C-Rad brand name. The company's endoMulti platform is a digital x-ray equipment with an ionizing radiation emitter and an advanced linac electronics module; and its endoDose platform includes linac platforms that are equipped with C-Rad's advanced dosimetry software. It also provides LINACsystems; and therapeutic linear accelerators and their subsystems. The company markets its products directly to customers through a global network of distributors. The company is based in Uppsala, Sweden.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇸🇪 Sweden